{{Rsnum
|rsid=11767191
|Chromosome=7
|position=48778369
|Orientation=plus
|GMAF=0.4164
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 49.6 | 19.5
| HCB | 51.1 | 38.7 | 10.2
| JPT | 47.8 | 44.2 | 8.0
| YRI | 35.4 | 50.3 | 14.3
| ASW | 28.1 | 59.6 | 12.3
| CHB | 51.1 | 38.7 | 10.2
| CHD | 35.8 | 51.4 | 12.8
| GIH | 25.7 | 58.4 | 15.8
| LWK | 30.9 | 50.9 | 18.2
| MEX | 32.8 | 50.0 | 17.2
| MKK | 33.5 | 49.7 | 16.8
| TSI | 22.5 | 54.9 | 22.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=1E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}